Search results
Explosive Ethereum (ETH) Growth, $4,000 Incoming? Shiba Inu (SHIB) Secures Breakthrough, XRP Needs...
Investing.com· 11 hours agoThe surge triggered more than $260 million in liquidations and pushed Ethereum above $3,600,...
Biden jumps on Trump ‘unified Reich’ video that plays into a key theme of president’s reelection...
CNN.com· 60 minutes agoPresident Joe Biden and his campaign are looking to capitalize on former President Donald Trump’s...
Egypt changed terms of Gaza ceasefire deal presented to Hamas, surprising negotiators, sources say
CNN via Yahoo News· 3 hours agoEgyptian intelligence quietly changed the terms of a ceasefire proposal that Israel had already...
How to qualify for competitive rates on low-interest personal loans
Bankrate via Yahoo Finance· 1 day agoYour DTI is the final number, expressed as a percentage. In general, and especially with low...
Rite Aid Advisers Asked to Cut Their Bills as Cash Squeezed
Bloomberg via Yahoo Finance· 25 minutes ago(Bloomberg) -- Some Rite Aid Corp. creditors have asked advisers representing the bankrupt pharmacy...
Ether Surges 17%, Polymarket Approval Chances Rocket as ETF Makes Regulatory Progress
CoinDesk via Yahoo Finance· 1 day agoThe U.S. SEC has asked exchanges to update 19b-4 filings for ether ETFs ahead of a key deadline,...
Key NH House members threaten to vote against cannabis bill after Senate changes
Portsmouth Herald via Yahoo News· 6 hours agoAnita Burroughs, a Bartlett Democrat and key sponsor of the bill, in an interview Monday. The latest...
Ethereum price forecast amid possible ETF approval By Investing.com
Investing.com· 1 day agoThe crypto rally on Tuesday was chiefly led by Ether, with the world’s second-largest crypto asset...
Foreign Purchase of U.S. Ammo Maker Sparks National-Security Battle
The Wall Street Journal· 11 hours agoShareholders are also expected to vote on the CSG deal then. Vista’s leadership expects the CSG...
Eli Lilly's diabetes drug tirzepatide gets approval in China
Reuters via Yahoo Finance· 1 day agoNovo Nordisk's popular diabetes drug Ozempic won approval from China in 2021 and the company saw...